18:16 18/01/2017 Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) current consensus investment ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) current consensus investment ...
The Independent Republic - 5 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock is presently standing at about $1.38 and lots of equity research firms seem to have a target price set on the stock.
Rating Sentiment to Follow: How Many Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ... - Fair View Times
Arena Pharmaceuticals Inc. (ARNA) Moves Lower on Volume Spike for January 17 - Equities.com

14:57 18/01/2017 Healthcare Stocks Flagged As Top Movers: Arena Pharmaceuticals, Inc. (NASDAQ ...
Healthcare Stocks Flagged As Top Movers: Arena Pharmaceuticals, Inc. (NASDAQ ...
TWN - 9 hours ago
Sell-side analyst recommendations point to a short term price target of $3.75 on the shares of Arena Pharmaceuticals, Inc. (ARNA). The consensus rating is 2.7, suggesting the market has given up on the stock. It has been assigned a low target price of ...

14:36 18/01/2017 Stocks to Concentrate: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , Neurocrine ...
Stocks to Concentrate: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , Neurocrine ...
WsNews 4investors - 9 hours ago
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) showed negative change of -2.82% while the stock's final trade was registered at $ 1.38.

15:36 17/01/2017 Heavy Volume Healthcare Stocks: Sangamo Therapeutics, Inc. (NASDAQ:SGMO ...
Heavy Volume Healthcare Stocks: Sangamo Therapeutics, Inc. (NASDAQ:SGMO ...
TWN - Jan 17, 2017
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) shares ended at $4.4 with 2 mln shares exchanging hands. That puts the market capitalization at $310.72 mln.

12:40 17/01/2017 Scorching Hot Biotech Stocks Tape: Arena Pharmaceuticals, Inc. (ARNA), Celsion ...
Scorching Hot Biotech Stocks Tape: Arena Pharmaceuticals, Inc. (ARNA), Celsion ...
The Independent Republic - Jan 17, 2017
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of -2.07 percent. It trades at an average volume of 1.57M shares versus 1.96M shares recorded at the end of last trading session.

22:30 12/01/2017 Arena Pharmaceuticals Inc. (ARNA) Moves Higher on Volume Spike for January 12
Arena Pharmaceuticals Inc. (ARNA) Moves Higher on Volume Spike for January 12
Equities.com - Jan 12, 2017
Arena Pharmaceuticals Inc. (ARNA) traded on unusually high volume on Jan. 12, as the stock gained 2.84% to close at $1.45. On the day, Arena Pharmaceuticals Inc. saw 2.63 million shares trade hands on 5,714 trades. Considering that the stock averages ...
Arena Pharmaceuticals, Inc. (ARNA) Downgraded by Zacks Investment Research - Sports Perspectives
The Needham & Company LLC Reiterates “Hold” Rating for Arena Pharmaceuticals ... - DailyQuint

15:45 06/01/2017 Arena Pharma Loses Weight, Dumps Belviq (ARNA)
Arena Pharma Loses Weight, Dumps Belviq (ARNA)
Investopedia - Jan 6, 2017
Arena Pharmaceuticals Inc. (ARNA) restructured its partnership with its Japanese partner, Eisai Co. Ltd., under which it transferred the global rights to its anti-obesity drug Belviq to Eisai.
Biotech Stocks To Put On Your Watch List: Arena Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has amended its BELVIQ® supply agreement - Benchmark Monitor

21:00 04/01/2017 Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for ...
Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for ...
PR Newswire (press release) - Jan 4, 2017
SAN DIEGO, Jan. 4, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that it has amended its BELVIQ® (lorcaserin HCl) marketing and supply agreement with Eisai Co.
Arena Pharmaceuticals, Inc. (ARNA) Receives $3.75 Average PT from Brokerages - Sports Perspectives
Arena Turns Page On Belviq - Restructures Deal With Eisai - Seeking Alpha

12:00 28/12/2016 Two Biotech Stocks Are Just So Hot Right Now: Arena Pharmaceuticals, Inc ...
Two Biotech Stocks Are Just So Hot Right Now: Arena Pharmaceuticals, Inc ...
The Independent Republic - Dec 28, 2016
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of 0 percent. It trades at an average volume of 1.54M shares versus 1.78M shares recorded at the end of last trading session.

18:31 19/12/2016 Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ ...
Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ ...
PR Newswire (press release) - Dec 19, 2016
WOODCLIFF LAKE, N.J. and SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that Eisai Laboratórios Ltda.